[Ip-health] Bridges Weekly: Bayer Challenges India Compulsory License Ruling

Daniella Allam dallam at ictsd.ch
Thu May 10 01:10:17 PDT 2012

Bayer Challenges India Compulsory License
German pharmaceutical company Bayer AG has formally lodged a challenge
against a landmark Indian ruling that allowed a domestic generic drug-maker
to produce a low-cost version of an anti-cancer drug for the Indian market.
The appeal was filed on Friday 4 May with India's Intellectual Property
Appellate Board.

Read more here:  http://ictsd.org/i/news/bridgesweekly/132882/

Connect with ICTSD's Programme on Innovation, Technology and IP on Facebook
and Twitter--


More information about the Ip-health mailing list